Page 5 - Childrens National - NIAID 3rd Annual Symposium_2020_Brochure
P. 5
CN-NIAID Symposium
.....................................................
Agenda Tuesday, September 29, 2020
9:00-10:00 am.......
Opening with Leadership
WELCOME | Kurt Newman, M.D., Children's National
OVERVIEW OF SARS-CoV-2 | Anthony S. Fauci, M.D., NIAID
ROLE OF NCATS IN THE COVID-19 RESPONSE | Christopher P. Austin, M.D., NCATS
10:10-12:10 pm.......
Immunobiology and Host Genomics
HUMORAL IMMUNE RESPONSE | Jeffrey I. Cohen, M.D., NIAID
CELLULAR RESPONSE (T AND NK CELLS) | Michael Keller, M.D., Children's National
IMMUNOPATHOGENESIS OF MIS-C | Sarah E. Henrickson, M.D., Ph.D., CHOP
GENOMIC FACTORS IN SARS-CoV-2 | Helen Su, M.D., Ph.D, NIAID
12:10-12:40 pm.......
Break
12:40-2:10 pm...........
Epidemiology and Clinical Manifestations
HEALTH DISPARITIES AND SARS-CoV-2 | Akilah Jefferson Shah, M.D., M.Sc., UAMS
CLINICAL SPECTRUM OF SARS-CoV-2, IMPLICATION FOR SCHOOLS REOPENING |
Dan M. Cooper, M.D., UC Irvine
MIS-C and Post SARS-CoV-2 MONITORING IN CHILDREN |
Roberta DeBiasi, M.D., M.S., Children's National
POST- SARS-CoV-2 MONITORING IN ADULTS | Michael C. Sneller, M.D., NIAID
2:20-3:50 pm...........
Treatment Strategies
OVERVIEW OF VACCINE CANDIDATES | Peter Hotez, M.D., Ph.D., Baylor
CURRENT STATE OF VACCINE TRIALS | Julie Ledgerwood, D.O., NIAID
ONGOING THERAPEUTIC TRIALS AND TREATMENT GUIDELINES |
Cliff Lane, M.D., NIAID
4:00-4:30 pm............
Closing
SARS-CoV-2 WHAT COMES NEXT- SOCIETAL/ECONOMIC IMPACT |
Ezekiel Emanuel, M.D., Ph.D., UPenn
W W W . C T S I C N . O R G 5
